Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Topical pharmacotherapy for skin cancer
Giuseppe Micali, Francesco Lacarrubba, Maria Rita Nasca, et al.
Journal of the American Academy of Dermatology (2014) Vol. 70, Iss. 6, pp. 965.e1-965.e12
Closed Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
Ketty Peris, Maria Concetta Fargnoli, Claus Garbe, et al.
European Journal of Cancer (2019) Vol. 118, pp. 10-34
Open Access | Times Cited: 512
Nanoparticles for topical drug delivery: Potential for skin cancer treatment
Vinu Krishnan, Samir Mitragotri
Advanced Drug Delivery Reviews (2020) Vol. 153, pp. 87-108
Closed Access | Times Cited: 159
Natural Compounds in Non-Melanoma Skin Cancer: Prevention and Treatment
Szymon Kowalski, Julia Karska, Maciej Tota, et al.
Molecules (2024) Vol. 29, Iss. 3, pp. 728-728
Open Access | Times Cited: 17
Updates on the Management of Non-Melanoma Skin Cancer (NMSC)
Artur Fahradyan, Anna C. Howell, Erik M. Wolfswinkel, et al.
Healthcare (2017) Vol. 5, Iss. 4, pp. 82-82
Open Access | Times Cited: 168
Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology
Thomas Dirschka, G. Gupta, Giuseppe Micali, et al.
Journal of Dermatological Treatment (2016) Vol. 28, Iss. 5, pp. 431-442
Open Access | Times Cited: 102
Quality by design case study 1: Design of 5-fluorouracil loaded lipid nanoparticles by the W/O/W double emulsion — Solvent evaporation method
Gülin Amasya, Ulya Badıllı, Buket Aksu, et al.
European Journal of Pharmaceutical Sciences (2016) Vol. 84, pp. 92-102
Closed Access | Times Cited: 87
QbD guided early pharmaceutical development study: Production of lipid nanoparticles by high pressure homogenization for skin cancer treatment
Gülin Amasya, Buket Aksu, Ulya Badıllı, et al.
International Journal of Pharmaceutics (2019) Vol. 563, pp. 110-121
Closed Access | Times Cited: 86
Ingenol mebutate in cancer therapy: mechanisms, clinical applications and future directions
Ndapewoshali F. Shafombabi, Michael G. Knott, Petrina Kapewangolo, et al.
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access | Times Cited: 1
Actinic keratosis – review for clinical practice
Erika C. V. de Oliveira, Valéria R. V. da Motta, Paola C. Pantoja, et al.
International Journal of Dermatology (2018) Vol. 58, Iss. 4, pp. 400-407
Closed Access | Times Cited: 81
Is inflammatory micronucleation the key to a successful anti-mitotic cancer drug?
Timothy J. Mitchison, Javier Pineda, Jue Shi, et al.
Open Biology (2017) Vol. 7, Iss. 11, pp. 170182-170182
Open Access | Times Cited: 74
An Overview of Biotransformation and Toxicity of Diterpenes
Ingrid Pontes de Sousa, Maria Valdeline Sousa Teixeira, Niege Araçari Jacometti Cardoso Furtado
Molecules (2018) Vol. 23, Iss. 6, pp. 1387-1387
Open Access | Times Cited: 73
Co-encapsulation of imiquimod and copaiba oil in novel nanostructured systems: promising formulations against skin carcinoma
Cristina G. Venturini, Franciele Aline Bruinsmann, Renata Vidor Contri, et al.
European Journal of Pharmaceutical Sciences (2015) Vol. 79, pp. 36-43
Closed Access | Times Cited: 65
Basal Cell Carcinoma: A Comprehensive Review of Existing and Emerging Nonsurgical Therapies.
Julien Lanoue, Gary Goldenberg
PubMed (2016) Vol. 9, Iss. 5, pp. 26-36
Closed Access | Times Cited: 63
Multiple molecular targets in breast cancer therapy by betulinic acid
Runlan Luo, Dengyang Fang, Peng Chu, et al.
Biomedicine & Pharmacotherapy (2016) Vol. 84, pp. 1321-1330
Closed Access | Times Cited: 63
pH-Responsive Nanostructures Based on Surface Active Fatty Acid-Protic Ionic Liquids for Imiquimod Delivery in Skin Cancer Topical Therapy
Silvia Tampucci, Lorenzo Guazzelli, Susi Burgalassi, et al.
Pharmaceutics (2020) Vol. 12, Iss. 11, pp. 1078-1078
Open Access | Times Cited: 59
A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions
Laura Del Regno, Silvia Catapano, Alessandro Di Stefani, et al.
American Journal of Clinical Dermatology (2022) Vol. 23, Iss. 3, pp. 339-352
Open Access | Times Cited: 34
Towards therapeutic advances in melanoma management: An overview
Swarnendra Singh, Atif Zafar, Shahper N. Khan, et al.
Life Sciences (2017) Vol. 174, pp. 50-58
Closed Access | Times Cited: 52
Mediators of Inflammation in Topical Therapy of Skin Cancers
Vlad Mihai Voiculescu, Cristina Lisievici, Mihai Lupu, et al.
Mediators of Inflammation (2019) Vol. 2019, pp. 1-15
Open Access | Times Cited: 48
Actinic keratosis. Features of pathogenesis, modern approaches to diagnosis and therapy
O.I. Chernyakova, A.A. Suvorova, A. A. Vashkevich, et al.
Russian Journal of Clinical Dermatology and Venereology (2025) Vol. 24, Iss. 2, pp. 227-227
Closed Access
Topical Therapy for non-invasive penile cancer (Tis)—updated results and toxicity
Aditya Manjunath, Thomas Brenton, S. Wylie, et al.
Translational Andrology and Urology (2017) Vol. 6, Iss. 5, pp. 803-808
Open Access | Times Cited: 34
The Bacterial Product Violacein Exerts an Immunostimulatory Effect Via TLR8
Francisco A. Venegas, Gabriele Köllisch, Kerstin Mark, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 32
Actinic keratosis: where do we stand and where is the future going to take us?
Philipp Cramer, Eggert Stockfleth
Expert Opinion on Emerging Drugs (2020) Vol. 25, Iss. 1, pp. 49-58
Closed Access | Times Cited: 31
Topical treatment of melanoma skin metastases with Imiquimod: a review
Andrea Sisti, Giovanni Sisti, Carlo M. Oranges
Dermatology Online Journal (2015) Vol. 21, Iss. 2
Open Access | Times Cited: 31
Anti-cancer activity of ZnO chips by sustained zinc ion release
Seong‐Hee Moon, Won Jin Choi, Sik‐Won Choi, et al.
Toxicology Reports (2016) Vol. 3, pp. 430-438
Open Access | Times Cited: 28
Systemic administration of a TLR7 agonist attenuates regulatory T cells by dendritic cell modification and overcomes resistance to PD-L1 blockade therapy
Naoto Nishii, Hidetake Tachinami, Yuta Kondo, et al.
Oncotarget (2018) Vol. 9, Iss. 17, pp. 13301-13312
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top